Caryn E. Good

2.0k citations

40 papers · 1.4k indexed · 1 hit paper · h-index 18

Impact in

Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Applied Microbiology and Biotechnology top 2%

Papers in ⓘ

Applied Microbiology and Biotechnology 6
- Antibiotic Use and Resistance 6
Molecular Medicine 13
- Antibiotic Resistance in Bacteria 13

Co-authors: Michael R. Jacobs (37 shared papers)Saralee Bajaksouzian (13 shared papers)Anne Windau (9 shared papers)Hillard M. Lazarus (4 shared papers)Roslyn Yomtovían (2 shared papers)Robert A. Bonomo (12 shared papers)Robert W. Maitta (2 shared papers)Hong Hong (1 shared paper)
Journals: Journal of Clinical Microbiology (8 papers)Antimicrobial Agents and Chemotherapy (8 papers)Transfusion (4 papers)Open Forum Infectious Diseases (3 papers)Clinical Infectious Diseases (2 papers)
Partner nations: United States South Africa United Kingdom

In The Last Decade

Caryn E. Good

36 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

Parabacteroides distasonis : intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health 2021 · 200 citations

Peers

Countries citing papers authored by Caryn E. Good

Since Specialization

Citations

This map shows the geographic impact of Caryn E. Good's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caryn E. Good with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caryn E. Good more than expected).

Fields of papers citing papers by Caryn E. Good

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caryn E. Good. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caryn E. Good. The network helps show where Caryn E. Good may publish in the future.

Co-authors

The 25 scholars most cited alongside Caryn E. Good, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Caryn E. Good Line = papers co-authored together Caryn E. Good links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Parabacteroides distasonis : intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health Gut Microbes ·Jessica C. Ezeji, Daven K. Sarikonda, Austin Hopperton, Hailey L. Erkkila, Daniel E. Cohen, Sandra P. Martinez, Fabio Cominelli, Tomomi Kuwahara, Armand E. K. Dichosa, Caryn E. Good, Michael R. Jacobs, Mikhail V. Khoretonenko, A.C.M. Veloo, Alexander Rodriguez‐Palacios Hit paper breakdown →	2021	200
2	Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance Blood ·Hong Hong, Wenbin Xiao, Hillard M. Lazarus, Caryn E. Good, Robert W. Maitta, Michael R. Jacobs	2015	146
3	Relationship between Bacterial Load, Species Virulence, and Transfusion Reaction with Transfusion of Bacterially Contaminated Platelets Clinical Infectious Diseases ·Michael R. Jacobs, Caryn E. Good, Hillard M. Lazarus, Roslyn Yomtovían	2008	129
4	Emergence ofStreptococcus pneumoniaeSerotypes 19A, 6C, and 22F and Serogroup 15 in Cleveland, Ohio, in Relation to Introduction of the Protein‐Conjugated Pneumococcal Vaccine Clinical Infectious Diseases ·Michael R. Jacobs, Caryn E. Good, Saralee Bajaksouzian, Anne Windau	2008	112
5	Targeting Multidrug-Resistant Acinetobacter spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent mBio ·Melissa D. Barnes, Vijay Kumar, Christopher R. Bethel, Samir H. Moussa, John P. O’Donnell, Joseph Rutter, Caryn E. Good, Kristine M. Hujer, Andrea M. Hujer, Steve H. Marshall, Barry N. Kreiswirth, Sandra S. Richter, Philip N. Rather, Michael R. Jacobs, Krisztina M. Papp‐Wallace, Focco van den Akker, Robert A. Bonomo	2019	95
6	ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum β-Lactamases and Carbapenemases Antimicrobial Agents and Chemotherapy ·Michael R. Jacobs, Ayman M. Abdelhamed, Caryn E. Good, Daniel D. Rhoads, Kristine M. Hujer, Andrea M. Hujer, Tatiana Domitrovic, Susan D. Rudin, Sandra S. Richter, David van Duin, Barry N. Kreiswirth, Chris Greco, Derrick E. Fouts, Robert A. Bonomo	2018	89
7	Detection of bacterial contamination in prestorage culture‐negative apheresis platelets on day of issue with the Pan Genera Detection test Transfusion ·Michael R. Jacobs, Daniel Smith, W. Andrew Heaton, Nicole D. Zantek, Caryn E. Good, (unknown)	2011	84
8	Changes in Serotypes and Antimicrobial Susceptibility of Invasive Streptococcus pneumoniae Strains in Cleveland: a Quarter Century of Experience Journal of Clinical Microbiology ·Michael R. Jacobs, Caryn E. Good, Bernard Beall, Saralee Bajaksouzian, Anne Windau, Cynthia G. Whitney	2008	66
9	Activity of Ceftaroline against Recent Emerging Serotypes of Streptococcus pneumoniae in the United States Antimicrobial Agents and Chemotherapy ·Michael R. Jacobs, Caryn E. Good, Anne Windau, Saralee Bajaksouzian, Donald Biek, Ian A. Critchley, Hélio S. Sader, Ronald N. Jones	2010	61
10	Occurrence, Distribution, and Origins of Streptococcus pneumoniae Serotype 6C, a Recently Recognized Serotype Journal of Clinical Microbiology ·Michael R. Jacobs, Saralee Bajaksouzian, Robert A. Bonomo, Caryn E. Good, Anne Windau, Andrea M. Hujer, Christian Massire, Rachael Melton, Lawrence B. Blyn, David J. Ecker, Rangarajan Sampath	2008	59
11	Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPC Antimicrobial Agents and Chemotherapy ·Melissa D. Barnes, Magdalena A. Taracila, Caryn E. Good, Saralee Bajaksouzian, Laura J. Rojas, David van Duin, Barry N. Kreiswirth, Michael R. Jacobs, Andreas Haldimann, Krisztina M. Papp‐Wallace, Robert A. Bonomo	2019	41
12	Evaluation of Updated Interpretative Criteria for Categorizing Klebsiella pneumoniae with Reduced Carbapenem Susceptibility Journal of Clinical Microbiology ·Andrea Endimiani, Federico Pérez, Saralee Bajaksouzian, Anne Windau, Caryn E. Good, Yuvraj Choudhary, Andrea M. Hujer, Christopher R. Bethel, Robert A. Bonomo, Michael R. Jacobs	2010	40
13	Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based on pharmacodynamic parameters: 1998–2001 U.S. Surveillance Study Clinics in Laboratory Medicine ·Michael R. Jacobs, Saralee Bajaksouzian, Anne Windau, Caryn E. Good, Gengrong Lin, Glenn A. Pankuch, Peter C. Appelbaum	2004	35
14	Multicenter Clinical Evaluation of BacT/Alert Virtuo Blood Culture System Journal of Clinical Microbiology ·Michael R. Jacobs, Tony Mazzulli, Kevin C. Hazen, Caryn E. Good, Ayman M. Abdelhamed, Pauline Lo, Bianche Shum, Katharine P. Roman, Danielle C. Robinson	2017	35
15	Activity of Retapamulin against Streptococcus pyogenes and Staphylococcus aureus Evaluated by Agar Dilution, Microdilution, E-Test, and Disk Diffusion Methodologies Antimicrobial Agents and Chemotherapy ·Glenn A. Pankuch, Gengrong Lin, Dianne B. Hoellman, Caryn E. Good, Michael R. Jacobs, Peter C. Appelbaum	2006	23
16	Complete Genome Sequence of a Parabacteroides distasonis Strain (CavFT hAR46) Isolated from a Gut Wall-Cavitating Microlesion in a Patient with Severe Crohn’s Disease Microbiology Resource Announcements ·Falong Yang, Anand Kumar, Karen W. Davenport, Julia M. Kelliher, Jessica C. Ezeji, Caryn E. Good, Michael R. Jacobs, Mathew Conger, Gail West, Claudio Fiocchi, Fabio Cominelli, Armand Earl Ko Dichosa, Alexander Rodriguez‐Palacios	2019	21
17	Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicine Transfusion ·Michael R. Jacobs, Caryn E. Good, Robert M. Fox, Katharine P. Roman, Hillard M. Lazarus	2013	17
18	Evaluation of a rapid colorimetric assay for detection of bacterial contamination in apheresis and pooled random‐donor platelet units Transfusion ·W. Andrew Heaton, Caryn E. Good, Rakijah Galloway‐Haskins, Roslyn Yomtovían, Michael R. Jacobs	2014	17
19	Activity of nitazoxanide and tizoxanide against Mycobacterium tuberculosis in vitro and in whole blood culture Tuberculosis ·Elizabeth Harausz, Keith Chervenak, Caryn E. Good, Michael R. Jacobs, Robert S. Wallis, Manuel Sánchez-Félix, W. Henry Boom	2016	16
20	Nasopharyngeal Carriage of Respiratory Pathogens in Children Undergoing Pressure Equalization Tube Placement in the Era of Pneumococcal Protein Conjugate Vaccine Use The Laryngoscope ·Michael R. Jacobs, Caryn E. Good, Tom Sellner, Saralee Bajaksouzian, Anne Windau, Jack B. Anon	2007	15

About Caryn E. Good

Caryn E. Good is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Clinical Biochemistry, Biochemistry and Pharmacology, having authored 40 papers that have together received 1.4k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (13 papers), Pneumonia and Respiratory Infections (10 papers), Bacterial Identification and Susceptibility Testing (9 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Antibiotic Use and Resistance (6 papers), Blood transfusion and management (5 papers) and Mycobacterium research and diagnosis (5 papers). The work is most often cited by research in Molecular Medicine (322 citations), Applied Microbiology and Biotechnology (104 citations), Biochemistry (284 citations), Microbiology (183 citations) and Management of Technology and Innovation (200 citations). Caryn E. Good has collaborated with scholars based in United States, South Africa and United Kingdom. Frequent co-authors include Michael R. Jacobs, Saralee Bajaksouzian, Anne Windau, Hillard M. Lazarus, Roslyn Yomtovían, Robert A. Bonomo, Robert W. Maitta, Hong Hong, Wenbin Xiao and Andrea M. Hujer. Their work appears in journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy, Transfusion, Open Forum Infectious Diseases and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact